These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29309927)

  • 21. GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells.
    Duda P; Akula SM; Abrams SL; Steelman LS; Gizak A; Rakus D; McCubrey JA
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118770. PubMed ID: 32524999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSK-3 as potential target for therapeutic intervention in cancer.
    McCubrey JA; Steelman LS; Bertrand FE; Davis NM; Sokolosky M; Abrams SL; Montalto G; D'Assoro AB; Libra M; Nicoletti F; Maestro R; Basecke J; Rakus D; Gizak A; Demidenko ZN; Cocco L; Martelli AM; Cervello M
    Oncotarget; 2014 May; 5(10):2881-911. PubMed ID: 24931005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review).
    He R; Du S; Lei T; Xie X; Wang Y
    Oncol Rep; 2020 Dec; 44(6):2373-2385. PubMed ID: 33125126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activity.
    Buescher JL; Phiel CJ
    J Biol Chem; 2010 Mar; 285(11):7957-63. PubMed ID: 20080974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen Synthase Kinase 3: A Kinase for All Pathways?
    Patel P; Woodgett JR
    Curr Top Dev Biol; 2017; 123():277-302. PubMed ID: 28236969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis.
    Sophia J; Kiran Kishore T K; Kowshik J; Mishra R; Nagini S
    Sci Rep; 2016 Feb; 6():22192. PubMed ID: 26902162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.
    Walz A; Ugolkov A; Chandra S; Kozikowski A; Carneiro BA; O'Halloran TV; Giles FJ; Billadeau DD; Mazar AP
    Clin Cancer Res; 2017 Apr; 23(8):1891-1897. PubMed ID: 28053024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer.
    Lin J; Song T; Li C; Mao W
    Biochim Biophys Acta Mol Cell Res; 2020 May; 1867(5):118659. PubMed ID: 31978503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
    Yoshino Y; Ishioka C
    Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
    Takahashi-Yanaga F; Sasaguri T
    Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase.
    Sale EM; Hodgkinson CP; Jones NP; Sale GJ
    Biochemistry; 2006 Jan; 45(1):213-23. PubMed ID: 16388597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
    Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
    Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Possible Interactions and Therapeutic Roles of Lithium Chloride and Midkine on Cancer Treatment.
    Bilir A; Aynacioglu AS; Tuna MY
    Crit Rev Oncog; 2019; 24(1):35-45. PubMed ID: 31679218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer.
    Campa VM; Baltziskueta E; Bengoa-Vergniory N; Gorroño-Etxebarria I; Wesołowski R; Waxman J; Kypta RM
    Oncotarget; 2014 Sep; 5(18):8173-87. PubMed ID: 25327559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo.
    Tapia-Rojas C; Schüller A; Lindsay CB; Ureta RC; Mejías-Reyes C; Hancke J; Melo F; Inestrosa NC
    Biochem J; 2015 Mar; 466(2):415-30. PubMed ID: 25423492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
    Khor TO; Gul YA; Ithnin H; Seow HF
    Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Akt in cancer: Mediator and more.
    Revathidevi S; Munirajan AK
    Semin Cancer Biol; 2019 Dec; 59():80-91. PubMed ID: 31173856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of glycogen synthase kinase-3.
    Ougolkov AV; Billadeau DD
    Methods Mol Biol; 2008; 468():67-75. PubMed ID: 19099246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.